JBIO

Jade Biosciences, Inc. is a biotechnology company focused on developing innovative therapeutics for metabolic and liver diseases. The company utilizes its proprietary drug discovery platforms to identify novel targets and develop small molecule and biological therapies. Jade is advancing a pipeline of product candidates addressing conditions including non-alcoholic steatohepatitis (NASH), metabolic dysfunction-associated liver disease, and related metabolic disorders. The company employs advanced screening technologies and translational research to accelerate drug development.